Apolipoprotein Isoform E4 Does Not Increase Coronary Heart Disease Risk in Carriers of Low-Density Lipoprotein Receptor Mutations.

MLA

Versmissen, Jorie, et al. “Apolipoprotein Isoform E4 Does Not Increase Coronary Heart Disease Risk in Carriers of Low-Density Lipoprotein Receptor Mutations.” Circulation: Cardiovascular Genetics, vol. 4, no. 6, Dec. 2011, pp. 655–60. EBSCOhost, https://doi.org/10.1161/CIRCGENETICS.111.959858.

APA

Versmissen, J., Oosterveer, D. M., Hoekstra, M., Out, R., Berbre, J. F. P., Blommesteijn-Touw, A. C., van Vark-van der Zee, L., Vongpromek, R., Vanmierlo, T., Defesche, J. C., Mulder, M., Kastelein, J. J. P., & Sijbrands, E. J. G. (2011). Apolipoprotein Isoform E4 Does Not Increase Coronary Heart Disease Risk in Carriers of Low-Density Lipoprotein Receptor Mutations. Circulation: Cardiovascular Genetics, 4(6), 655–660. https://doi.org/10.1161/CIRCGENETICS.111.959858

Chicago

Versmissen, Jorie, Daniëlla M. Oosterveer, Menno Hoekstra, Ruud Out, Jimmy F. P. Berbre, Adriana C. Blommesteijn-Touw, Leonie van Vark-van der Zee, et al. 2011. “Apolipoprotein Isoform E4 Does Not Increase Coronary Heart Disease Risk in Carriers of Low-Density Lipoprotein Receptor Mutations.” Circulation: Cardiovascular Genetics 4 (6): 655–60. doi:10.1161/CIRCGENETICS.111.959858.